Fundz

Immuto Scientific has closed an $8M Seed 2 financing round and initiated a collaboration with Daiichi Sankyo to develop new cancer targets using its platform.

PRIVATESep 18, 2025

Amount Raised

$8 Million

Round Type

Seed

CambridgeBiotechnologyTherapeuticsresearch

Description

Immuto Scientific announced the closing of an oversubscribed $8 million Seed 2 financing round and a collaboration with Daiichi Sankyo. The company will use its AI-enabled structural surfaceomics platform in drug discovery. These funds will help advance its internal oncology pipeline and explore new areas like immunology. The collaboration aims to identify new targets in solid tumors and develop antibodies.

Quick answer

Immuto Scientific raised $8 Million in a Seed round, dated September 18, 2025. Immuto Scientific is based in Cambridge, Massachusetts, United States.

How much did Immuto Scientific raise?
Immuto Scientific raised $8 Million in a Seed round on September 18, 2025.
What does Immuto Scientific do?
Immuto is a biotechnology company that is transforming the way biotherapeutics are discovered.
Where is Immuto Scientific based and how big is it?
Immuto Scientific is based in Cambridge, Massachusetts, United States. Fundz records about 17 employees.
Who are the decision-makers at Immuto Scientific?
Fundz holds 1 contact at Immuto Scientific. Names and contact details are shown to Fundz members.

Source: Fundz verified event record.

Who else raised in Therapeutics and research around the same time

Companies in the same sectors as Immuto Scientific that raised within 45 days of this round, from Fundz verified event records.

  • Faeth Therapeutics raised $25M (Funding Round) on October 20, 2025.
  • Aarvik Therapeutics raised an undisclosed amount (Seed) on September 29, 2025.
  • Corner Therapeutics raised $17M on September 26, 2025.
  • Intensity Therapeutics raised $4M (Post-IPO Equity) on October 31, 2025.
  • CoRegen raised $14M on October 28, 2025.
  • Hemab Therapeutics raised $157M (Series C) on October 27, 2025.

Who to call at Immuto Scientific, and when

A new round usually means Immuto Scientific is about to hire and buy. The teams that reach out first get the meeting.

  • An alert the day Immuto Scientific raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at Immuto Scientific, from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at Immuto Scientific. With Fundz connected, it knows.

Watch Fundz in
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Company Information

Company

Immuto Scientific

Location

1 Broadway

Cambridge, Massachusetts, United States

About

Immuto is a biotechnology company that is transforming the way biotherapeutics are discovered. Protein structural analysis is an essential step in the drug discovery process, and compared to all other methods used today, our suite of proprietary technologies enables assessment of drug binding, target conformation, and interactions with an unprecedented degree of accuracy and speed. With our industry leading structure-based platform, we enable the discovery of next generation therapeutics against the most challenging targets.‍‍ Using our patented approach, we are on a mission to demystify and democratize protein structure, function, and dynamics - driving rationally designed drug development at unprecedented speed. Unlock rational design for biologics and reimagine drug discovery with us.

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment Immuto Scientific raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Related People

1 contact
Predictive Intelligence
Strategic

ML-powered predictions for Immuto Scientific's next move

See what Strategic adds

Immuto Scientific raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.